<- Go Home
Tactile Systems Technology, Inc.
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Market Cap
$525.3M
Volume
321.3K
Cash and Equivalents
$75.0M
EBITDA
$38.8M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$262.4M
Profit Margin
76.39%
52 Week High
$37.77
52 Week Low
$9.34
Dividend
N/A
Price / Book Value
2.43
Price / Earnings
26.29
Price / Tangible Book Value
3.89
Enterprise Value
$465.5M
Enterprise Value / EBITDA
10.97
Operating Income
$32.3M
Return on Equity
9.59%
Return on Assets
7.31
Cash and Short Term Investments
$75.0M
Debt
$15.2M
Equity
$217.9M
Revenue
$343.5M
Unlevered FCF
$33.9M
Sector
Health Care Equipment and Supplies
Category
N/A